References
- Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993;27:341–8
- Alla F, Kearney-Schwartz A, Radauceanu A, et al. Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes. Eur J Heart Fail 2006;8:147–53
- Lord E, Ledoux S, Murphy BD, et al. Expression of adiponectin receptors in swine. J Anim Sci 2005;83:565–78
- Fujioka D, Kawabata K, Saito Y, et al. Role of adiponectin receptors in endothelin-induced hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol 2006;290:H2409–16
- Shibata R, Ouchi N, Ito M, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nature 2004;12:1384–9
- Shibata R, Izumiya Y, Sato K, et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 2007;42:1065–74
- Fujita K, Maeda N, Sonoda M, et al. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR–alpha. Arterioscler Thromb Vasc Biol 2008;28:863–70
- Paakko T, Ukkola O, Ikaheimo M, Kesäniemi YA. Plasma APN levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects. Ann Med 2010;42:131–7
- Ybarra J, Resmini E, Planas F, et al. Relationship between APN and left atrium size in uncomplicated obese patients: APN, a link between fat and heart. Obes Surg 2009;19:1324–32
- Mitsuhashi H, Yatsuya H, Tamakoshi K, et al. APN level and left ventricular hypertrophy in Japanese men. Hypertension 2007;49:1448–54
- McManus DD, Lyass A, Ingelsson E, et al. Relationship of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study. Obesity 2012;20:1882–6
- Hong SJ, Park CG, Seo HS, et al. Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Pressure 2004;13:236–42
- Sam F, Duhaney TA, Sato K, et al. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure. Endocrinology 2010;151:322–31
- Plaksej R, Kosmala W, Frantz S, et al. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure. J Hypertens 2009;27:2483–91
- Kosmala W, Plaksej R, Strotmann JM, et al. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study. J Am Soc Echocardiogr 2008;21:1309–17
- Imbalzano E, Zito C, Carerj S, et al. Left ventricular function in hypertension: new insight by speckle tracking echocardiography. Echocardiography 2011;28:649–57
- Kang SJ, Lim HS, Choi BJ, et al. Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension. J Am Soc Echocardiogr 2008;21:907–11
- Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550–8
- Lang RM, Bierig M, Devereux RB, et al. Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines Standards Committee European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–63
- Komuro I, Katoh Y, Kaida T, et al. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. J Biol Chem 1991;266:1265–8
- Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991;69:107–15
- Chan AYM, Soltys CLM, Young ME, et al. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in cardiac myocytes. J Biol Chem 2004;279:32771–9
- Duda MK, O’Shea KM, Lei B, et al. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 2007;76:303–10